{"id":"W4399273548","doi":"10.3899/jrheum.2023-1198","title":"Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials","year":2024,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Ankylosing spondylitis; Placebo; Internal medicine; Post-hoc analysis; Adverse effect; Gastroenterology; C-reactive protein; Sulfasalazine; Tofacitinib; BASDAI; Spondylitis; Concomitant; Rheumatoid arthritis; Disease; Pathology; Inflammation; Psoriatic arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02388626,0.002751729,0.006367467,0.0008548036,0.0004574437,0.00261915,0.001110899,0.001169877,0.006250428],"category_scores_gemma":[0.01506808,0.0006964374,0.009874497,0.0009847451,0.0009898221,0.001706487,0.0008464386,0.003160981,0.0008212959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001243187,"about_ca_system_score_gemma":0.002743921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004802377,"about_ca_topic_score_gemma":0.0009921734,"domain_scores_codex":[0.9865106,0.009297404,0.001022466,0.001208792,0.001073243,0.0008875842],"domain_scores_gemma":[0.9814269,0.01068431,0.003889342,0.001704935,0.001403643,0.000890855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.92664,0.003235439,0.008247473,0.001803345,0.03372112,0.0000875174,0.0000924807,0.002536,0.004979919,0.0001924055,0.002478092,0.01598612],"study_design_scores_gemma":[0.3561543,0.4193917,0.1150844,0.0003861891,0.07076544,0.0003313847,0.0002329068,0.01256348,0.01383352,0.00129772,0.009723885,0.0002352254],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9549258,0.01019587,0.006620812,0.000657549,0.0009462265,0.0109069,0.008970492,0.0003679318,0.006408344],"genre_scores_gemma":[0.9707868,0.002134585,0.004606029,0.0008681662,0.0005372368,0.01309957,0.003751759,0.0002052716,0.004010603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02388626,"threshold_uncertainty_score":0.1263241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06805273882172985,"score_gpt":0.415941915718198,"score_spread":0.3478891768964681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}